Clinical Trial Site

Toronto, Ontario N6H5L4

5 studies enrolling now · 13 studies all time

What they study most

Advanced Breast Cancer, Atypical Hemolytic-Uremic Syndrome, Breast Cancer, Chronic Hepatitis B, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, Hypertension, Lichen Planopilaris, Locally Advanced Breast Cancer, Metastatic Breast Cancer, Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder

Studies at this site

• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris — Recruiting now
• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. — Recruiting now
• Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Recruiting now
• Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer — Completed
• BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1) — Running, not enrolling
• HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Running, not enrolling
• A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension — Completed
• Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) — Completed
• Natural History of Patients With PH3 and a History of Stone Events — Completed
• A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder — Stopped early
• Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B — Stopped early